menu
    • menu

    Company profile for Iambic Therapeutics

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Lambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters with strong track records of success in delivering clinically validated therapeutics. The Iambic platform has been demonstrated to deliver high-quality, differentiated therapeutics to clinics with unprecedented spee...
    Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Lambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters with strong track records of success in delivering clinically validated therapeutics. The Iambic platform has been demonstrated to deliver high-quality, differentiated therapeutics to clinics with unprecedented speed and across multiple target classes and mechanisms of action. The Iambic team is advancing an internal pipeline of clinical assets to address urgent unmet patient needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Iambic TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5627 Oberlin Drive, Suite 120 San Diego, CA 92121
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.iambic.ai/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/iambic-ai/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/iambic_ai

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Iambic To Participate In March Investor Conferences
    Iambic To Participate In March Investor Conferences

    02 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260302662667/en/Iambic-to-Participate-in-March-Investor-Conferences

    BUSINESSWIRE
    02 Mar 2026
    Share Share
    Takeda Inks $1.7B AI Discovery Deal With Iambic Therapeutics
    Takeda Inks $1.7B AI Discovery Deal With Iambic Therapeutics

    09 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/takeda-inks-17b-ai-discovery-deal-iambic-therapeutics

    FIERCE BIOTECH
    09 Feb 2026
    Share Share
    Iambic Therapeutics To Present At J.P. Morgan Health Conference
    Iambic Therapeutics To Present At J.P. Morgan Health Conference

    16 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251216538314/en/Iambic-Therapeutics-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    16 Dec 2025
    Share Share
    Iambic Therapeutics Lines Up Over $100M In New Funding
    Iambic Therapeutics Lines Up Over $100M In New Funding

    10 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/busy-ai-driven-iambic-therapeutics-raises-over-100m-oversubscribed-funding-round

    FIERCE BIOTECH
    10 Nov 2025
    Share Share
    Iambic To Participate In November Investor Conferences
    Iambic To Participate In November Investor Conferences

    04 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251104266121/en/Iambic-to-Participate-in-November-Investor-Conferences

    BUSINESS WIRE
    04 Nov 2025
    Share Share
    Iambic Collaborates With Jazz Pharma On Her2+ Breast Cancer Study
    Iambic Collaborates With Jazz Pharma On Her2+ Breast Cancer Study

    21 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251021091520/en/Iambic-Announces-Research-Collaboration-with-Jazz-Pharmaceuticals-for-IAM1363-and-Zanidatamab-Combination-Cohort-in-HER2-Positive-Breast-Cancer

    BUSINESSWIRE
    21 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search